InnovAge Holding Corp. (INNV) - Stock Analysis
Last updated: Mar 14, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
InnovAge (INNV) demonstrates strong operational turnaround with positive adjusted EBITDA, expanding participant base, joint ventures for growth, and robust technical momentum with a 47% stock increase over a month. Its sustainable earnings and strategic partnerships support near-term appreciation potential in healthcare services.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Positive EBITDA ⢠Improved liquidity ⢠Elevated multiples INNV returned to quarterly profitability and stronger liquidity (EBITDA +$17.4M, net income +$10.6M, cash +$19.1M) with reduced leverage, but valuation remains rich and balance-sheet composition (large intangibles/payables) warrants caution.
Price Behavior
Key Price Behavior Insights: ⢠Failed breakout ⢠Below last-month SMA ⢠Large intraperiod range Support Level: $8.00â$8.20 Resistance Level: $9.30â$9.50 Rallied quickly from ~$8.35 to $10.60 but failed to sustain above ~$9.5, pulled back toward the $8.0â$8.2 support and now trades below its last-month average (~$8.81), signaling weakening short-term momentum amid high (~30%) volatility.
Sentiment & News
Key News Insights: ⢠Double-digit growth ⢠Analyst upgrades ⢠Technical support Analyst upgrades, independent buy ratings, and improving fundamentalsâ14.7% revenue growth, margin expansion, and positive estimate/technical signalsâhave fueled renewed upside interest and an ~8.5% stock pop.
AI Summary
InnovAge has transitioned from a binary turnaround to an operationally credible, cash-generating growth operator, but its current premium valuation fully prices continued margin expansion so the investment thesis now hinges on flawless execution of member/capitation growth and disciplined de novo rollouts. Monitor the next 2â3 quarters for sustained adjusted EBITDA margin expansion, predictable FCF growth, and de novo loss containmentâif those metrics falter (or Medicaid redeterminations and wage/integration costs accelerate), downside risk is material.
Description
InnovAge Holding Corp. operates a Program of All-Inclusive Care for the Elderly (PACE) model, delivering both in-home and center-based medical and support services for seniors who require assistance to remain in their communities. The company serves about 6,850 participants through 18 centers across Colorado, California, New Mexico, Pennsylvania and Virginia, and offers care management, skilled and personal care, therapy, dental and mental health services, meals and transportation. Founded in 2007 and headquartered in Denver, it adopted the InnovAge name in January 2021.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Feb 5 | Feb 12 | INNV | InnovAge Holding Corp. | InnovAge (INNV) demonstrates strong operational turnaround with positive adjusted EBITDA, expanding participant base, joint ventures for growth, and robust technical momentum with a 47% stock increase over a month. Its sustainable earnings and strategic partnerships support near-term appreciation potential in healthcare services. | Closed | +11.8% |